WOLVERINE ASSET MANAGEMENT LLC - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 34 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2023$6,293
+17.2%
87,8930.0%0.00%
Q2 2023$5,370
+52.4%
87,8930.0%0.00%
Q1 2023$3,524
-7.0%
87,8930.0%0.00%
Q4 2022$3,788
-36.9%
87,893
+8.9%
0.00%
Q3 2022$6,000
-25.0%
80,6890.0%0.00%
Q2 2022$8,000
-52.9%
80,6890.0%0.00%
Q1 2022$17,000
-48.5%
80,6890.0%0.00%
Q4 2021$33,00080,6890.00%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q4 2021
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 163,538$1,636,0000.09%
Telemetry Investments, L.L.C. 121,614$23,0000.04%
Radcliffe Capital Management, L.P. 150,000$1,501,0000.03%
Q Global Advisors, LLC 170,785$37,0000.02%
CANTOR FITZGERALD, L. P. 363,548$79,0000.01%
Atalaya Capital Management LP 225,000$50,0000.01%
MMCAP International Inc. SPC 375,000$82,0000.01%
Bulldog Investors, LLP 54,745$11,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 108,741$24,0000.00%
Context Capital Management, LLC 200,000$44,0000.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders